TGFB1 and breast carcinoma: Considering the possibility that cancer cells undergoing EMT may acquire additional properties of immune cells, we performed gene profiling analysis of breast cancer cells that had been allowed to adopt an EMT program after treatment with TGF‐β for 2 weeks.